We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Structure and Behavior of Collagen Revealed Utilizing Photon Technology

By Biotechdaily staff writers
Posted on 17 Mar 2008
The structure and behavior of one of the most common proteins have been resolved at a level of clarity never before seen, due to recently developed technology.

The new research was performed by investigators from the Advanced Photon Source (APS) at the U.S. More...
Department of Energy's (DOE) Argonne U.S. National Laboratory (Argonne, IL, USA). Illinois Institute of Technology (Chicago, IL, USA) biologist Dr. Joseph Orgel used the high-energy X-rays produced by the APS to examine the structure of collagen, a protein that composes more than one-quarter of all proteins in the human body and forms the principal component of skin, teeth, ligaments, the heart, blood vessels, bones, and cartilage. In these tissues, collagen molecules bunch themselves into overlapping bundles called fibrils. These fibrils, each containing billions of atoms, entangle themselves into collagen fibers that are visible to the naked eye.

Scientists have known the basic molecular structure of collagen since the 1950s, when several different international groups of scientists discovered that it had a triple-stranded helical structure. However, researches had never before had the ability to evaluate the structure of an entire fibril in the same way that they could study an individual collagen molecule, according to Dr. Orgel.

Dr. Orgel and his team performed diffraction studies on intact collagen fibrils inside the tendons of rat-tails to determine just how the protein functioned within unbroken tissue. "We tried to draw a highly accurate map of the molecular structure of tissues,” Dr. Orgel said. "By doing so, we hope to transform a very basic understanding that we have of the molecular structure of tissue into a much more tangible form.”

Since the scientists kept the tendon tissue intact, they could see how the collagen molecule binds to collagenases, a class of enzymes which when working correctly, help to regulate the normal growth and development of animals but when malfunctioning can lead to the metastasis of cancerous tumors or rheumatoid arthritis. The visualization of this interaction could help drug developers to create an inhibitor to prevent the pathologic action of the enzyme, according to Dr. Orgel.

Earlier research of the structure of collagen had looked only at crystals of small fragments of the protein, so scientists had little knowledge of how it looked within intact tissue. "It's impossible to get the information that we did by removing tiny chunks of the tissue,” Dr. Orgel said. "We couldn't obtain these data by single-crystal crystallography. This research was made possible only because of the BioCAT beamline provided by the APS.”

The research was published in the February 26, 2008, issue of the Proceedings of the [U.S.] National Academy of Sciences (PNAS).


Related Links:
Argonne National Laboratory

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.